These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16804363)

  • 1. Leg ulcers in elderly on hydroxyurea: a single center experience in Ph- myeloproliferative disorders and review of literature.
    Ruzzon E; Randi ML; Tezza F; Luzzatto G; Scandellari R; Fabris F
    Aging Clin Exp Res; 2006 Jun; 18(3):187-90. PubMed ID: 16804363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
    Olesen LH; Pedersen BB
    Ugeskr Laeger; 2001 Dec; 163(49):6908-11. PubMed ID: 11766504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related?
    Bader U; Banyai M; Böni R; Burg G; Hafner J
    Dermatology; 2000; 200(1):45-8. PubMed ID: 10681614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea-induced leg ulceration in 14 patients.
    Best PJ; Daoud MS; Pittelkow MR; Petitt RM
    Ann Intern Med; 1998 Jan; 128(1):29-32. PubMed ID: 9424978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea induced perimalleolar ulcers.
    Saravu K; Velappan P; Lakshmi N; Shastry BA; Thomas J
    J Korean Med Sci; 2006 Feb; 21(1):177-9. PubMed ID: 16479088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea and lower leg ulcers.
    Nguyen TV; Margolis DJ
    Cutis; 1993 Oct; 52(4):217-9. PubMed ID: 8261806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea-induced leg ulcers treated with a protease-modulating matrix.
    Romanelli M; Dini V; Romanelli P
    Arch Dermatol; 2007 Oct; 143(10):1310-3. PubMed ID: 17938346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders.
    Randi ML; Ruzzon E; Luzzatto G; Tezza F; Girolami A; Fabris F
    Haematologica; 2005 Feb; 90(2):261-2. PubMed ID: 15710584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea induced skin ulceration in myeloproliferative disorders.
    McLintock C; Ockelford PA
    Aust N Z J Med; 2000 Jun; 30(3):373-6. PubMed ID: 10914756
    [No Abstract]   [Full Text] [Related]  

  • 11. Painful leg ulcers and a rash in a patient with polycythaemia rubra vera. Diagnosis: hydroxyurea-induced leg ulceration and dermatomyositis-like skin changes.
    Haniffa MA; Speight EL
    Clin Exp Dermatol; 2006 Sep; 31(5):733-4. PubMed ID: 16901329
    [No Abstract]   [Full Text] [Related]  

  • 12. Aggressive, extensive, vasculitic leg ulceration associated with hydroxyurea therapy and a fatal outcome.
    Young HS; Kirby B; Stewart EJ
    Clin Exp Dermatol; 2001 Nov; 26(8):664-7. PubMed ID: 11722451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leg ulcers and hydroxyurea: report of three cases with essential thrombocythemia.
    Demirçay Z; Cömert A; Adigüzel C
    Int J Dermatol; 2002 Dec; 41(12):872-4. PubMed ID: 12492973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea-induced genital ulcers and erosions: Two case reports.
    Blum AE; Tsiaras WG; Kemp JM
    J Tissue Viability; 2021 Aug; 30(3):462-464. PubMed ID: 34147315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic factor?
    Vélez A; García-Aranda JM; Moreno JC
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):243-4. PubMed ID: 10461646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous ulcers associated with hydroxyurea therapy in myeloproliferative disorders.
    Ravandi-Kashani F; Cortes J; Cohen P; Talpaz M; O'Brien S; Markowitz A; Kantarjian H
    Leuk Lymphoma; 1999 Sep; 35(1-2):109-18. PubMed ID: 10512168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Leg ulcer in a patient treated with hydroxyurea for polycythemia vera].
    Hanchi I; Zeglaoui F; Ezzine N; Daoud L; Karoui M; Fazaa B; Ridha Kamoun M
    Presse Med; 2006; 35(7-8):1174-6. PubMed ID: 16840894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and side effects of hydroxyurea used for primary thrombocythemia.
    Randi ML; Ruzzon E; Tezza F; Luzzatto G; Fabris F
    Platelets; 2005; 16(3-4):181-4. PubMed ID: 16011962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications.
    Weinfeld A; Swolin B; Westin J
    Eur J Haematol; 1994 Mar; 52(3):134-9. PubMed ID: 8168592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leg ulcers associated with long-term hydroxyurea therapy.
    Weinlich G; Schuler G; Greil R; Kofler H; Fritsch P
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 2):372-4. PubMed ID: 9703157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.